Quarterly report · Q2

Period2022-04-01 → 2022-09-30
Filed2022-11-11
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 46
MetricValuePeriodScopeSource row
Revenue¥9.1bn2022-04-01 → 2022-09-30Cons.Net sales
Revenue¥16.3bn2021-04-01 → 2022-03-31Cons.Net sales (5-year summary)
Revenue¥8.4bn2021-04-01 → 2021-09-30Cons.Net sales
Operating income¥1.2bn2022-04-01 → 2022-09-30Cons.Operating income
Operating income¥1.2bn2021-04-01 → 2021-09-30Cons.Operating income
Ordinary income¥1.3bn2022-04-01 → 2022-09-30Cons.Ordinary income
Ordinary income¥2.1bn2021-04-01 → 2022-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥1.3bn2021-04-01 → 2021-09-30Cons.Ordinary income
Profit before tax¥1.3bn2022-04-01 → 2022-09-30Cons.Income before income taxes
Profit before tax¥1.3bn2021-04-01 → 2021-09-30Cons.Income before income taxes
Net income (owners)¥848m2022-04-01 → 2022-09-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥1.9bn2021-04-01 → 2022-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥1.5bn2021-04-01 → 2021-09-30Cons.Profit loss attributable to owners of parent
Net income¥926m2022-04-01 → 2022-09-30Cons.Profit loss
Net income¥1.5bn2021-04-01 → 2021-09-30Cons.Profit loss
Total assets¥27.5bnat 2022-09-30Cons.Assets
Total assets¥26.6bnat 2022-03-31Cons.Assets
Total assets¥26.0bnat 2021-09-30Cons.Total assets (5-year summary)
Total liabilities¥6.2bnat 2022-09-30Cons.Liabilities
Total liabilities¥5.8bnat 2022-03-31Cons.Liabilities
Net assets / equity¥21.4bnat 2022-09-30Cons.Net assets
Net assets / equity¥20.8bnat 2022-03-31Cons.Net assets
Net assets / equity¥20.5bnat 2021-09-30Cons.Net assets (5-year summary)
Cash and deposits¥12.9bnat 2022-09-30Cons.Cash and deposits
Cash and deposits¥11.9bnat 2022-03-31Cons.Cash and deposits
Cash & equivalents¥12.9bnat 2022-09-30Cons.Cash and cash equivalents
Cash & equivalents¥11.9bnat 2022-03-31Cons.Cash and cash equivalents
Cash & equivalents¥11.4bnat 2021-09-30Cons.Cash and cash equivalents
Cash & equivalents¥9.7bnat 2021-03-31dCons.Cash and cash equivalents
Operating cash flow¥1.2bn2022-04-01 → 2022-09-30Cons.Net cash provided by used in operating activities
Operating cash flow¥1.1bn2021-04-01 → 2022-03-31Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥254m2021-04-01 → 2021-09-30Cons.Net cash provided by used in operating activities
Investing cash flow¥232m2022-04-01 → 2022-09-30Cons.Net cash provided by used in investment activities
Investing cash flow¥432m2021-04-01 → 2022-03-31Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow¥659m2021-04-01 → 2021-09-30Cons.Net cash provided by used in investment activities
Financing cash flow−¥486m2022-04-01 → 2022-09-30Cons.Net cash provided by used in financing activities
Financing cash flow¥568m2021-04-01 → 2022-03-31Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow¥802m2021-04-01 → 2021-09-30Cons.Net cash provided by used in financing activities
EPS (basic)¥110.62022-04-01 → 2022-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥67.942022-07-01 → 2022-09-30dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥250.582021-04-01 → 2022-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥187.252021-04-01 → 2021-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥101.752021-07-01 → 2021-09-30dCons.Basic earnings loss per share (5-year summary)
Equity ratio73.7%at 2022-09-30Cons.Equity to asset ratio (5-year summary)
Equity ratio74.5%at 2022-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio75.2%at 2021-09-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 18
SegmentItemPeriodValue
jpcrp040300-q2r_E02333-000Medical Relatedreportable segmentrevenue2022-04-01 → 2022-09-30¥1.2bn
jpcrp040300-q2r_E02333-000Medical Relatedreportable segmentrevenue external2022-04-01 → 2022-09-30¥1.2bn
jpcrp040300-q2r_E02333-000Medical Relatedreportable segmentsegment profit2022-04-01 → 2022-09-30¥138m
jpcrp040300-q2r_E02333-000Water Health Carereportable segmentrevenue2022-04-01 → 2022-09-30¥7.9bn
jpcrp040300-q2r_E02333-000Water Health Carereportable segmentrevenue external2022-04-01 → 2022-09-30¥7.9bn
jpcrp040300-q2r_E02333-000Water Health Carereportable segmentsegment profit2022-04-01 → 2022-09-30¥1.1bn
—segment totalrevenue2022-04-01 → 2022-09-30¥9.1bn
—segment totalrevenue external2022-04-01 → 2022-09-30¥9.1bn
—segment totalsegment profit2022-04-01 → 2022-09-30¥1.2bn
jpcrp040300-q2r_E02333-000Medical Relatedreportable segmentrevenue2021-04-01 → 2021-09-30¥938m
jpcrp040300-q2r_E02333-000Medical Relatedreportable segmentrevenue external2021-04-01 → 2021-09-30¥938m
jpcrp040300-q2r_E02333-000Medical Relatedreportable segmentsegment profit2021-04-01 → 2021-09-30¥81m
jpcrp040300-q2r_E02333-000Water Health Carereportable segmentrevenue2021-04-01 → 2021-09-30¥7.5bn
jpcrp040300-q2r_E02333-000Water Health Carereportable segmentrevenue external2021-04-01 → 2021-09-30¥7.5bn
jpcrp040300-q2r_E02333-000Water Health Carereportable segmentsegment profit2021-04-01 → 2021-09-30¥1.1bn
—segment totalrevenue2021-04-01 → 2021-09-30¥8.4bn
—segment totalrevenue external2021-04-01 → 2021-09-30¥8.4bn
—segment totalsegment profit2021-04-01 → 2021-09-30¥1.2bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 503
ItemContextValueUnit
Share of other comprehensive income of associates accounted for using equity method ociPrior1YTDDuration574000JPY
Share of other comprehensive income of associates accounted for using equity method ociCurrentYTDDuration859000JPY
Other comprehensive incomePrior1YTDDuration35692000JPY
Other comprehensive incomeCurrentYTDDuration119901000JPY
Comprehensive incomePrior1YTDDuration1553173000JPY
Comprehensive incomeCurrentYTDDuration1046168000JPY
Comprehensive income attributable to owners of the parentPrior1YTDDuration1482690000JPY
Comprehensive income attributable to owners of the parentCurrentYTDDuration921435000JPY
Comprehensive income attributable to non controlling interestsPrior1YTDDuration70482000JPY
Comprehensive income attributable to non controlling interestsCurrentYTDDuration124732000JPY
Income before income taxesPrior1YTDDuration1253195000JPY
Income before income taxesCurrentYTDDuration1324331000JPY
Depreciation and amortization ope cfPrior1YTDDuration202202000JPY
Depreciation and amortization ope cfCurrentYTDDuration192021000JPY
Amortization of goodwill ope cfPrior1YTDDuration18559000JPY
Amortization of goodwill ope cfCurrentYTDDuration18559000JPY
Increase decrease in allowance for doubtful accounts ope cfPrior1YTDDuration-2970000JPY
Increase decrease in allowance for doubtful accounts ope cfCurrentYTDDuration1653000JPY
Increase decrease in provision for bonuses ope cfPrior1YTDDuration3860000JPY
Increase decrease in provision for bonuses ope cfCurrentYTDDuration9178000JPY
Increase decrease in provision for loss on contract ope cfPrior1YTDDuration-31895000JPY
Increase decrease in provision for loss on contract ope cfCurrentYTDDuration-JPY
Interest and dividends income ope cfPrior1YTDDuration-10666000JPY
Interest and dividends income ope cfCurrentYTDDuration-11192000JPY
Interest expenses ope cfPrior1YTDDuration2424000JPY
Interest expenses ope cfCurrentYTDDuration548000JPY
Equity in earnings losses of affiliates ope cfPrior1YTDDuration-1606000JPY
Equity in earnings losses of affiliates ope cfCurrentYTDDuration-3439000JPY
Stock issuance cost ope cfPrior1YTDDuration6219000JPY
Stock issuance cost ope cfCurrentYTDDuration-JPY
Going public expenses ope cfPrior1YTDDuration9378000JPY
Going public expenses ope cfCurrentYTDDuration-JPY
Gain on reversal of subscription rights to shares ope cfPrior1YTDDuration-JPY
Gain on reversal of subscription rights to shares ope cfCurrentYTDDuration-28720000JPY
Decrease increase in notes and accounts receivable trade ope cfPrior1YTDDuration-112204000JPY
Decrease increase in notes and accounts receivable trade ope cfCurrentYTDDuration-545850000JPY
Decrease increase in accounts receivable installment ope cfPrior1YTDDuration56592000JPY
Decrease increase in accounts receivable installment ope cfCurrentYTDDuration-JPY
Decrease increase in inventories ope cfPrior1YTDDuration-104799000JPY
Decrease increase in inventories ope cfCurrentYTDDuration-12500000JPY
Increase decrease in notes and accounts payable trade ope cfPrior1YTDDuration-439025000JPY
Increase decrease in notes and accounts payable trade ope cfCurrentYTDDuration-20730000JPY
Increase decrease in advances received ope cfPrior1YTDDuration-55534000JPY
Increase decrease in advances received ope cfCurrentYTDDuration185722000JPY
Increase decrease in accrued consumption taxes ope cfPrior1YTDDuration-74347000JPY
Increase decrease in accrued consumption taxes ope cfCurrentYTDDuration97180000JPY
Other net ope cfPrior1YTDDuration48795000JPY
Other net ope cfCurrentYTDDuration67613000JPY
Subtotal ope cfPrior1YTDDuration768178000JPY
Subtotal ope cfCurrentYTDDuration1274375000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2022-03-31pass rounding
balance sheet identityconsolidated 2022-09-30pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2022-03-31pass
statement vs summary · net assetsconsolidated 2022-09-30pass
statement vs summary · net income attributable to parentconsolidated 2021-04-01/2021-09-30pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-09-30pass
statement vs summary · operating cash flowconsolidated 2021-04-01/2021-09-30pass
statement vs summary · operating cash flowconsolidated 2022-04-01/2022-09-30pass
statement vs summary · revenueconsolidated 2021-04-01/2021-09-30pass
statement vs summary · revenueconsolidated 2022-04-01/2022-09-30pass
statement vs summary · total assetsconsolidated 2022-03-31pass
statement vs summary · total assetsconsolidated 2022-09-30pass